Home

Alembic Pharmaceuticals Ltd EPS

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

EPS

₹ 30.26

Last updated on: Apr 02, 2025

Key Highlights

  • The Earning per Share of Alembic Pharmaceuticals Ltd is ₹ 30.26 as of 02 Apr 25 .
  • The earning per share of Alembic Pharmaceuticals Ltd changed from ₹ 6.14 to ₹ 7.01 over 7 quarters. This represents a CAGR of 7.87% .

Historical Earning per Share of Alembic Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Alembic Pharmaceuticals Ltd

Market Cap

17,399 Cr

EPS

30.3

P/E Ratio (TTM)

29.3

P/B Ratio (TTM)

3.6

Day’s High

924.6

Day’s Low

885.0

DTE

0.2

ROE

13.2

52 Week High

1296.15

52 Week Low

725.6

ROCE

12.8

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Apr 2025885.2
01 Apr 2025897.55
28 Mar 2025929.25
27 Mar 2025930.9
26 Mar 2025904.75
25 Mar 2025935.25
24 Mar 2025963.3
21 Mar 2025947.75
20 Mar 2025834.15
19 Mar 2025841.7

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Alembic Pharmaceuticals Ltd

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

17,400

Asset Value

Value addition

4.1 X

3,379

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Alembic Pharmaceuticals Ltd17399
Sun Pharmaceutical Industries Ltd411306
Divis Laboratories Ltd150343
Cipla Ltd117323
Torrent Pharmaceuticals Ltd108614
Mankind Pharma Ltd99891

Historical Market Cap of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Alembic Pharmaceuticals Ltd News Hub

Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f

Read more

13 Aug 24

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa

Read more

13 Aug 24

Alembic Pharmaceuticals Ltd leads losers in 'A' group

Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t

Read more

09 Aug 24

Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr

Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J

Read more

08 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

FAQs for EPS of Alembic Pharmaceuticals Ltd

What is the EPS of Alembic Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Alembic Pharmaceuticals Ltd is 30.26. An EPS is the amount of net income attributed to each share of a common stock.

How is Alembic Pharmaceuticals Ltd EPS calculated?

The EPS of Alembic Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Alembic Pharmaceuticals Ltd report its EPS?

Alembic Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Alembic Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Alembic Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Alembic Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Alembic Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions